BUFFALO, N.Y. — University at Buffalo neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into how the medication, often described as a wonder drug, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback